Wellmune WGP® Reduces Upper Respiratory Tract Infection Symptoms and Improves Mood States, Study Finds

The body of research demonstrating that Wellmune WGP® can reduce upper respiratory tract infection symptoms and improve the psychological well-being of individuals with stressful lifestyles continued to grow this week with the presentation of new data at Experimental Biology 2010.

In a study of 122 healthy volunteers (32 men, 90 women 38 + 12y), participants taking 250 mg of Wellmune WGP daily for 12 weeks reported a statistically significant (p<0.05) 58% reduction in upper respiratory tract infection symptoms, compared with individuals taking a placebo. Wellmune WGP is a natural carbohydrate that activates key immune cells and is a product of Biothera, a Minnesota biotechnology company focused on immune health.

Using a Profile of Mood States (POMS) psychological survey to assess changes in mental and physical energy levels and overall well-being, the study demonstrated statistically significant benefits for the Wellmune WGP group.

These participants rated their overall well-being and vigor 9.5% and 11% higher, respectively, compared with the placebo group. Data for both measures had p values of <0.05.

“As we have seen in previous peer-reviewed, published studies, Wellmune WGP can naturally enhance immune responses during periods of high stress,” said Don Cox, Ph.D., Biothera vice president of Research and Development. “Maintaining a healthy immune system is critical to maintaining overall health and vitality.”

GLH Nutrition, which conducted the study on behalf of Biothera, is an independent research & development organization that evaluates ingredients for food, beverage and dietary supplements. These studies are presented at scientific conferences and appear in peer-reviewed journals and lay-audience publications. Through its educational website, SupplementWatch www.supplementwatch.com <http://www.supplementwatch.com> , GLH Nutrition educates consumers and health professionals about the pros and cons of choosing and using dietary supplements.

Since it won an Institute of Food Technologist (IFT) Innovation Award three years ago during its introduction, Wellmune WGP has become an ingredient in numerous supplements, foods and beverages worldwide, including:

• Oasis® Immuniforce juices and smoothies from Lassonde, one of the largest refrigerated juice companies in Canada.
• Praeventia cookies from Groupe Biscuits Leclerc, a Canadian company that manufactures cookies, snack bars, crackers, and breakfast cereals, and exports to more than 20 countries.
• Nutrafizz® effervescent beverages available in stickpack or tablet form from Nutrafizz Corp., USA.
• Healthyshot®, an immune-enhancing powder mix for supplementing foods and beverages, from Diamond Crystal, a division of Hormel, USA.
• Immiflex®, a dietary supplement from Immicare, UK.
• GPS®, a dietary supplement from Nippon Biothera, Japan.

About Wellmune WGP®
Wellmune WGP is a natural ingredient that is clinically proven to enhance key immune cells that are the body¹s first line of defense. Designed for functional foods, beverages and supplements, Wellmune WGP strengthens innate immune cells to more quickly find and kill foreign challenges. Wellmune WGP also enhances the immune system to protect against the harmful effects of physical or lifestyle stress. Wellmune WGP is patented, GRAS, TGA-approved, Kosher, Halal, non-allergenic and GMO-free. The ingredient is recipient of an IFT Innovation Award and a Frost & Sullivan Excellence in Research Award.

Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health. More information is available at www.wellmune.com <http://www.wellmune.com>.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.